CAND1 Promotes PLK4-Mediated Centriole Overduplication and Is Frequently Disrupted in Prostate Cancer

Por Korzeniewski, Nina, Hohenfellner, Markus, Duensing, Stefan
Publicado em 2012

Infantile Enuresis: Current State-of-the-Art Therapy and Future Trends

Por Kuehhas, Franklin E, Djakovic, Nenad, Hohenfellner, Markus
Publicado em 2011

The current and future role of magnetic resonance imaging in prostate cancer detection and management

Por Radtke, Jan Philipp, Teber, Dogu, Hohenfellner, Markus, Hadaschik, Boris A.
Publicado no Transl Androl Urol (2015)

A young man with position-dependent erectile dysfunction: diagnostic work-up and interventional therapy of an arteriovenous malformation

Por Huber, Johannes, Schild, Hans H, Huber, Christian G, Hallscheidt, Peter, Hohenfellner, Markus
Publicado em 2011

Urinary Diversion—Approaches and Consequences

Por Stein, Raimund, Hohenfellner, Markus, Pahernik, Sascha, Roth, Stephan, Thüroff, Joachim W, Rübben, Herbert
Publicado em 2012

Harnessing the p53-PUMA Axis to Overcome DNA Damage Resistance in Renal Cell Carcinoma()

Por Zhou, Xiaoguang, Tolstov, Yanis, Arslan, Aysenur, Roth, Wilfried, Grüllich, Carsten, Pahernik, Sascha, Hohenfellner, Markus, Duensing, Stefan
Publicado no Neoplasia (2014)

Paraganglioma of the Seminal Vesicle Case Report and Review of the Literature

Por Tosev, Georgi, Mendler, Michael, Bergmann, Frank, Klein, Tilman, Pahernik, Sascha A., Hadaschik, Boris A., Hohenfellner, Markus
Publicado no J Endourol Case Rep (2016)

Expression and Functional Characterization of the BNIP3 Protein in Renal Cell Carcinomas

Por Macher-Goeppinger, Stephan, Keith, Martina, Hatiboglu, Gencay, Hohenfellner, Markus, Schirmacher, Peter, Roth, Wilfried, Tagscherer, Katrin E.
Publicado no Transl Oncol (2017)

The ribosomal protein S6 in renal cell carcinoma: functional relevance and potential as biomarker

Por Knoll, Maximilian, Macher-Goeppinger, Stephan, Kopitz, Jürgen, Duensing, Stefan, Pahernik, Sascha, Hohenfellner, Markus, Schirmacher, Peter, Roth, Wilfried
Publicado no Oncotarget (2015)

Current state of the art, multimodality research and future visions for the treatment of patients with prostate cancer: consensus results from “Challenges and Chances in Prostate C...

Por Combs, Stephanie E, Debus, Jürgen, Feick, Günter, Hadaschik, Boris, Hohenfellner, Markus, Schüle, Roland, Zacharias, Jens-Peter, Schwardt, Malte
Publicado no Radiat Oncol (2014)

Prospective single center trial of next-generation sequencing analysis in metastatic renal cell cancer: the MORE-TRIAL

Por Dieffenbacher, Svenja, Zschäbitz, Stefanie, Hofer, Luisa, Hatiboglu, Gencay, Hou, Weibin, Hohenfellner, Markus, Duensing, Stefan, Sültmann, Holger, Pahernik, Sascha, Grüllich, Carsten
Publicado no Future Sci OA (2018)

Primary melanoma of the prostate: case report and review of the literature

Por Tosev, Georgi, Kuru, Timur H., Huber, Johannes, Freier, Gerald, Bergmann, Frank, Hassel, Jessica C., Pahernik, Sascha A., Hohenfellner, Markus, Hadaschik, Boris A.
Publicado no BMC Urol (2015)

Evaluation of an Automated Analysis Tool for Prostate Cancer Prediction Using Multiparametric Magnetic Resonance Imaging

Por Roethke, Matthias C., Kuru, Timur H., Mueller-Wolf, Maya B., Agterhuis, Erik, Edler, Christopher, Hohenfellner, Markus, Schlemmer, Heinz-Peter, Hadaschik, Boris A.
Publicado no PLoS One (2016)

Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma

Por Pfitzenmaier Jesco, Schirmacher Peter, Hoppe-Seyler Karin, Hüsing Johannes, Pritsch Maria, Macher-Goeppinger Stephan, Wagener Nina, Haferkamp Axel, Hoppe-Seyler Felix, Hohenfellner Markus
Publicado em 2010-10-01

Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma

Por Wagener, Nina, Macher-Goeppinger, Stephan, Pritsch, Maria, Hüsing, Johannes, Hoppe-Seyler, Karin, Schirmacher, Peter, Pfitzenmaier, Jesco, Haferkamp, Axel, Hoppe-Seyler, Felix, Hohenfellner, Markus
Publicado em 2010

Decoy Receptor 3 Is a Prognostic Factor in Renal Cell Cancer

Por Macher-Goeppinger, Stephan, Aulmann, Sebastian, Wagener, Nina, Funke, Benjamin, Tagscherer, Katrin E, Haferkamp, Axel, Hohenfellner, Markus, Kim, Sunghee, Autschbach, Frank, Schirmacher, Peter, Roth, Wilfried
Publicado em 2008

Volumetry may predict early renal function after nephron sparing surgery in solitary kidney patients

Por Kuru, Timur H, Zhu, Jie, Popeneciu, Ionel V, Rudhardt, Nora S, Hadaschik, Boris A, Teber, Dogu, Roethke, Matthias, Hohenfellner, Markus, Zeier, Martin, Pahernik, Sascha A
Publicado em 2014

MET expression and copy number status in clear-cell renal cell carcinoma: prognostic value and potential predictive marker

Por Macher-Goeppinger, Stephan, Keith, Martina, Endris, Volker, Penzel, Roland, Tagscherer, Katrin E., Pahernik, Sascha, Hohenfellner, Markus, Gardner, Humphrey, Grüllich, Carsten, Schirmacher, Peter, Roth, Wilfried
Publicado no Oncotarget (2016)

Efficacy of Cabazitaxel Treatment in Metastatic Castration Resistant Prostate Cancer in Second and Later Lines. An Experience from Two German Centers

Por Zschäbitz, Stefanie, Vallet, Sonia, Hadaschik, Boris, Debatin, Daniel, Fuxius, Stefan, Karcher, Andreas, Pahernik, Sascha, Spath, Cathleen, Duensing, Stefan, Jäger, Dirk, Hohenfellner, Markus, Grüllich, Carsten
Publicado no J Cancer (2017)

Uncoupling of PUMA Expression and Apoptosis Contributes to Functional Heterogeneity in Renal Cell Carcinoma — Prognostic and Translational Implications()

Por Zhou, Xiaoguang, Li, Jielin, Marx, Christina, Tolstov, Yanis, Rauch, Geraldine, Herpel, Esther, Macher-Goeppinger, Stephan, Roth, Wilfried, Grüllich, Carsten, Pahernik, Sascha, Hohenfellner, Markus, Duensing, Stefan
Publicado no Transl Oncol (2015)